HEALTHglobal
Opinion: Semaglutide is going off-patent in India. But will people who need it be able to get it?
Single source
Updated 2 hours ago
First seen March 17, 2026 17:28:55Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
Rules determining who gets access to semaglutide in India were written for different bodies with different cardiovascular risks.